GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7EZF | P09467 | Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase | |
7EZP | P09467 | Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase | |
7EZR | P09467 | Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase | |
7EZZ | P0A232 | Crystal structure of Salmonella typhi outer membrane phospholipase (OMPLA) dimer with bound calcium | |
7F0L | 7F0L | STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX OF RHODOBACTER SPHAEROIDES MONOMER | |
7F0L | Q7B300 | STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX OF RHODOBACTER SPHAEROIDES MONOMER | |
7F0L | P0C0X9 | STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX OF RHODOBACTER SPHAEROIDES MONOMER | |
7F0L | A0A3G6WQU3 | STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX OF RHODOBACTER SPHAEROIDES MONOMER | |
7F0L | A0A330HGC2 | STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX OF RHODOBACTER SPHAEROIDES MONOMER | |
7F12 | P0DTC2 | A SARS-CoV-2 neutralizing antibody | |
7F12 | 7F12 | A SARS-CoV-2 neutralizing antibody | |
7F15 | P0DTC2 | A SARS-CoV-2 neutralizing antibody | |
7F15 | 7F15 | A SARS-CoV-2 neutralizing antibody | |
7F29 | B4DM00 | Cryo-EM structure of the fibril formed by disaccharide-modified amyloid-beta(1-42) | |
7F3Q | P0DTC2 | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
7F3Q | 7F3Q | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
7F46 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab) | |
7F46 | 7F46 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab) | |
7F56 | P42260 | DNQX-bound GluK2-1xNeto2 complex, with asymmetric LBD | |
7F56 | C6K2K4 | DNQX-bound GluK2-1xNeto2 complex, with asymmetric LBD | |
7F57 | P42260 | Kainate-bound GluK2-1xNeto2 complex, at the desensitized state | |
7F57 | C6K2K4 | Kainate-bound GluK2-1xNeto2 complex, at the desensitized state | |
7F59 | P42260 | DNQX-bound GluK2-1xNeto2 complex | |
7F59 | C6K2K4 | DNQX-bound GluK2-1xNeto2 complex | |
7F5A | P42260 | DNQX-bound GluK2-2xNeto2 complex | |
7F5A | C6K2K4 | DNQX-bound GluK2-2xNeto2 complex | |
7F5B | P42260 | LBD-TMD focused reconstruction of DNQX-bound GluK2-1xNeto2 complex | |
7F5B | C6K2K4 | LBD-TMD focused reconstruction of DNQX-bound GluK2-1xNeto2 complex | |
7F5G | P0DTC2 | The crystal structure of RBD-Nanobody complex, DL4 (SA4) | |
7F5G | 7F5G | The crystal structure of RBD-Nanobody complex, DL4 (SA4) | |
7F5H | P0DTC2 | The crystal structure of RBD-Nanobody complex, DL28 (SC4) | |
7F5H | 7F5H | The crystal structure of RBD-Nanobody complex, DL28 (SC4) | |
7F5J | A0A509GV09 | The crystal structure of VyPAL2-I244V, a more efficient mutant of VyPAL2 peptide asparaginyl ligase in its active enzyme form | |
7F5P | A0A509GV09 | The crystal structure of VyPAL2-C214A, a dead mutant of VyPAL2 peptide asparaginyl ligase in form I | |
7F5Q | A0A509GV09 | The crystal structure of VyPAL2 peptide asparaginyl ligase in its active enzyme form | |
7F5R | 7F5R | Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 | |
7F5R | P0DTC2 | Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 | |
7F6G | 7F6G | Cryo-EM structure of human angiotensin receptor AT1R in complex Gq proteins and Sar1-AngII | |
7F6G | P50148 | Cryo-EM structure of human angiotensin receptor AT1R in complex Gq proteins and Sar1-AngII | |
7F6G | P62873 | Cryo-EM structure of human angiotensin receptor AT1R in complex Gq proteins and Sar1-AngII | |
7F6G | P59768 | Cryo-EM structure of human angiotensin receptor AT1R in complex Gq proteins and Sar1-AngII | |
7F6Y | 7F6Y | Complex Structure of antibody BD-503 and RBD-E484K of COVID-19 | |
7F6Y | P0DTC2 | Complex Structure of antibody BD-503 and RBD-E484K of COVID-19 | |
7F6Z | 7F6Z | Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19 | |
7F6Z | P0DTC2 | Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19 | |
7F71 | I6Y9J2 | Crystal structure of the Mycobacterium tuberculosis L,D-transpeptidase-2 (LdtMt2) with peptidoglycan sugar moiety and glutamate | |
7F7E | 7F7E | SARS-CoV-2 S protein RBD in complex with A5-10 Fab | |
7F7E | P0DTC2 | SARS-CoV-2 S protein RBD in complex with A5-10 Fab | |
7F7F | P32660 | Cryo-EM structure of Dnf1 from Saccharomyces cerevisiae in yeast lipids with beryllium fluoride (resting state) | |
7F7F | P42838 | Cryo-EM structure of Dnf1 from Saccharomyces cerevisiae in yeast lipids with beryllium fluoride (resting state) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024